Global Immuno-Oncology Competitive Landscape Professional Research Report 2024

Global Immuno-Oncology Competitive Landscape Professional Research Report 2024

Research Summary

Immuno-oncology is a branch of cancer treatment that focuses on harnessing the body＇s immune system to recognize, target, and eliminate cancer cells. The field explores strategies to enhance the natural ability of the immune system to detect and destroy cancer cells, often by overcoming mechanisms that tumors use to evade immune detection. Immunotherapies in immuno-oncology include checkpoint inhibitors, adoptive cell transfer, cytokines, and cancer vaccines. Checkpoint inhibitors, such as PD-1 and CTLA-4 inhibitors, block proteins that inhibit immune responses, allowing T cells to recognize and attack cancer cells more effectively. Adoptive cell transfer involves manipulating a patient＇s own immune cells outside the body and then reintroducing them to target and destroy cancer cells. Immuno-oncology has shown promising results in treating various types of cancers and is a rapidly evolving field in the quest for more effective and targeted cancer therapies.

According to DIResearch's in-depth investigation and research, the global Immuno-Oncology market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.

The major global manufacturers of Immuno-Oncology include Bristol-Myers Squibb, Merck & Co., Inc., Roche AG, AstraZeneca, Plc, Sanofi S.A., Dendreon Pharmaceuticals, Novartis, Gilead Sciences Inc., Merck KGaA etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Immuno-Oncology. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Immuno-Oncology market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Immuno-Oncology market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Immuno-Oncology industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Immuno-Oncology Include:

Bristol-Myers Squibb

Merck & Co., Inc.

Roche AG

AstraZeneca, Plc

Sanofi S.A.

Dendreon Pharmaceuticals

Novartis

Gilead Sciences Inc.

Merck KGaA

Immuno-Oncology Product Segment Include:

Immune Checkpoint Inhibitors

Cytokine-Based Immunotherapy

Cancer Vaccines

CAR-T Cell Therapy

Others

Immuno-Oncology Product Application Include:

Hospitals

Drugstores

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Immuno-Oncology Industry PESTEL Analysis

Chapter 3: Global Immuno-Oncology Industry Porter’s Five Forces Analysis

Chapter 4: Global Immuno-Oncology Major Regional Market Size and Forecast Analysis

Chapter 5: Global Immuno-Oncology Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Immuno-Oncology Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Immuno-Oncology Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Immuno-Oncology Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Immuno-Oncology Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Immuno-Oncology Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Immuno-Oncology Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Immuno-Oncology Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources